M. Bélanger and P. Magistretti, The role of astroglia in neuroprotection, Dialogues Clin Neurosci, vol.11, pp.281-295, 2009.

K. Biber, M. Zuurman, H. Homan, and H. Boddeke, Expression of L-CCR in HEK 293 cells reveals functional responses to CCL2, CCL5, CCL7, and CCL8, Journal of Leukocyte Biology, vol.74, issue.2, pp.243-251, 2003.
DOI : 10.1189/jlb.0802415

K. Biber, A. Pinto-duarte, M. Wittendorp, A. Dolga, C. Fernandes et al., Interleukin-6 Upregulates Neuronal Adenosine A1 Receptors: Implications for Neuromodulation and Neuroprotection, Neuropsychopharmacology, vol.11, issue.9, pp.2237-2250, 2008.
DOI : 10.1517/14728214.8.2.537

D. Boison, J. Chen, and B. Fredholm, Adenosine signaling and function in glial cells, Cell Death and Differentiation, vol.939, issue.7, pp.1071-1082, 2010.
DOI : 10.1074/jbc.272.30.18518

A. Brand, Z. Vissiennon, D. Eschke, and K. Nieber, Adenosine A1 and A3 receptors mediate inhibition of synaptic transmission in rat cortical neurons, Neuropharmacology, vol.40, issue.1, pp.85-95, 2001.
DOI : 10.1016/S0028-3908(00)00117-9

J. Castillo, A. Dávalos, J. Naveiro, and M. Noya, Neuroexcitatory Amino Acids and Their Relation to Infarct Size and Neurological Deficit in Ischemic Stroke, Stroke, vol.27, issue.6, pp.1060-1065, 1996.
DOI : 10.1161/01.STR.27.6.1060

C. Chen, S. Liao, and J. Kuo, Gliotoxic Action of Glutamate on Cultured Astrocytes, Journal of Neurochemistry, vol.1, issue.4, pp.1557-1565, 2000.
DOI : 10.1046/j.1471-4159.2000.0751557.x

G. Chen, B. Harvey, H. Shen, J. Chou, A. Victor et al., Activation of adenosine A3 receptors reduces ischemic brain injury in rodents, Journal of Neuroscience Research, vol.23, issue.8, pp.1848-1855, 2006.
DOI : 10.1002/jnr.21071

D. Choi and S. Rothman, The Role of Glutamate Neurotoxicity in Hypoxic-Ischemic Neuronal Death, Annual Review of Neuroscience, vol.13, issue.1, pp.171-182, 1990.
DOI : 10.1146/annurev.ne.13.030190.001131

R. Ciccarelli, D. Iorio, P. Bruno, V. Battaglia, G. et al., Activation of A1 adenosine or mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S-100? protein from cultured astrocytes, Glia, vol.33, issue.3, pp.275-281, 1999.
DOI : 10.1002/(SICI)1098-1136(199909)27:3<275::AID-GLIA9>3.0.CO;2-0

R. Cipriani, P. Villa, G. Chece, C. Lauro, A. Paladini et al., CX3CL1 Is Neuroprotective in Permanent Focal Cerebral Ischemia in Rodents, Journal of Neuroscience, vol.31, issue.45, pp.16327-16335, 2011.
DOI : 10.1523/JNEUROSCI.3611-11.2011

R. Cunha, Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors, Neurochemistry International, vol.38, issue.2, pp.107-125, 2001.
DOI : 10.1016/S0197-0186(00)00034-6

E. Daré, G. Schulte, O. Karovic, C. Hammarberg, and B. Fredholm, Modulation of glial cell functions by adenosine receptors, Physiology & Behavior, vol.92, issue.1-2, pp.15-20, 2007.
DOI : 10.1016/j.physbeh.2007.05.031

D. Iorio, P. Kleywegt, S. Ciccarelli, R. Traversa, U. Andrew et al., Mechanisms of apoptosis induced by purine nucleosides in astrocytes, Glia, vol.29, issue.3, pp.179-190, 2002.
DOI : 10.1002/glia.10055

T. Dunwiddie, L. Diao, H. Kim, J. Jiang, and K. Jacobson, Activation of hippocampal adenosine A3 receptors produces a heterologous desensitization of A1 receptor mediated responses in rat hippocampus, J Neurosci, vol.17, pp.607-614, 1997.

E. Eugenin, D. Aversa, T. Lopez, L. Calderon, T. Berman et al., MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis, Journal of Neurochemistry, vol.108, issue.5, pp.1299-1311, 2003.
DOI : 10.1046/j.1471-4159.2003.01775.x

I. Fedorova, M. Jacobson, A. Basile, and K. Jacobson, Behavioral characterization of mice lacking the A3 adenosine receptor: sensitivity to hypoxic neurodegeneration, Cellular and Molecular Neurobiology, vol.23, issue.3, pp.431-447, 2003.
DOI : 10.1023/A:1023601007518

B. Fredholm, Adenosine, an endogenous distress signal, modulates tissue damage and repair, Cell Death and Differentiation, vol.10, issue.7, pp.1315-1323, 2007.
DOI : 10.1038/sj.cdd.4402132

B. Fredholm, J. Chen, R. Cunha, P. Svenningsson, and J. Vaugeois, Adenosine and Brain Function, Int Rev Neurobiol, vol.63, pp.191-270, 2005.
DOI : 10.1016/S0074-7742(05)63007-3

C. Gomes, M. Kaster, A. Tomé, P. Agostinho, and R. Cunha, Adenosine receptors and brain diseases: Neuroprotection and neurodegeneration, Biochimica et Biophysica Acta (BBA) - Biomembranes, vol.1808, issue.5, pp.1380-1399, 2011.
DOI : 10.1016/j.bbamem.2010.12.001
URL : http://doi.org/10.1016/j.bbamem.2010.12.001

G. Guillemin, J. Croitoru-lamoury, D. Dormont, P. Armati, and B. Brew, Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes, Glia, vol.393, issue.4, pp.371-381, 2003.
DOI : 10.1002/glia.10175

A. Guyon, D. Skrzydelski, D. Giry, I. Rovère, C. Conductier et al., Long term exposure to the chemokine CCL2 activates the nigrostriatal dopamine system: a novel mechanism for the control of dopamine release, Neuroscience, vol.162, issue.4, pp.1072-1080, 2009.
DOI : 10.1016/j.neuroscience.2009.05.048
URL : https://hal.archives-ouvertes.fr/hal-00419267

P. Hallett and D. Standaert, Rationale for and use of NMDA receptor antagonists in Parkinson's disease, Pharmacology & Therapeutics, vol.102, issue.2, pp.155-174, 2004.
DOI : 10.1016/j.pharmthera.2004.04.001

W. Huang, F. Yen, F. Shie, C. Pan, Y. Shiao et al., TGF-??1 blockade of microglial chemotaxis toward A?? aggregates involves SMAD signaling and down-regulation of CCL5, Journal of Neuroinflammation, vol.7, issue.1, pp.28-38, 2010.
DOI : 10.1186/1742-2094-7-28

K. Jacobson, S. Siddiqi, M. Olah, X. Ji, N. Melman et al., Structure-Activity Relationships of 9-Alkyladenine and Ribose-Modified Adenosine Derivatives at Rat A3 Adenosine Receptors, Journal of Medicinal Chemistry, vol.38, issue.10, pp.1720-1735, 1995.
DOI : 10.1021/jm00010a017

X. Ji, C. Gallo-rodriguez, and K. Jacobson, A Selective Agonist Affinity Label for A3 Adenosine Receptors, Biochemical and Biophysical Research Communications, vol.203, issue.1, pp.570-576, 1994.
DOI : 10.1006/bbrc.1994.2220

Y. Kusano, G. Echeverry, G. Miekisiak, T. Kulik, S. Aronhime et al., Role of Adenosine A2 Receptors in Regulation of Cerebral Blood Flow during Induced Hypotension, Journal of Cerebral Blood Flow & Metabolism, vol.29, issue.4, pp.808-815, 2010.
DOI : 10.1152/physrev.00021.2001

C. Lauro, D. Angelantonio, S. Cipriani, R. Sobrero, F. Antonilli et al., Activity of Adenosine Receptors Type 1 Is Required for CX3CL1-Mediated Neuroprotection and Neuromodulation in Hippocampal Neurons, The Journal of Immunology, vol.180, issue.11, pp.7590-7596, 2008.
DOI : 10.4049/jimmunol.180.11.7590

C. Lauro, R. Cipriani, M. Catalano, F. Trettel, G. Chece et al., Adenosine A1 Receptors and Microglial Cells Mediate CX3CL1-Induced Protection of Hippocampal Neurons Against Glu-Induced Death, Neuropsychopharmacology, vol.104, issue.7, pp.1550-1559, 2010.
DOI : 10.1016/S0165-5728(01)00259-4
URL : https://hal.archives-ouvertes.fr/hal-00514619

L. Le-blanc, A. Van-lieshout, G. Adema, P. Van-riel, M. Verbeek et al., CXCL16 is elevated in the cerebrospinal fluid versus serum and in inflammatory conditions with suspected and proved central nervous system involvement, Neuroscience Letters, vol.397, issue.1-2, pp.145-148, 2006.
DOI : 10.1016/j.neulet.2005.12.029

A. Liou, R. Clark, D. Henshall, X. Yin, and J. Chen, To die or not to die for neurons in ischemia, traumatic brain injury and epilepsy: a review on the stress-activated signaling pathways and apoptotic pathways, Progress in Neurobiology, vol.69, issue.2, pp.103-142, 2003.
DOI : 10.1016/S0301-0082(03)00005-4

S. Lipton, The Molecular Basis of Memantine Action in Alzheimers Disease and Other Neurologic Disorders: Low-affinity, Uncompetitive Antagonism, Current Alzheimer Research, vol.2, issue.2, pp.155-165, 2005.
DOI : 10.2174/1567205053585846

A. Ludwig, A. Schulte, C. Schnack, C. Hundhausen, K. Reiss et al., Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells, Journal of Neurochemistry, vol.303, issue.5, pp.1293-12303, 2005.
DOI : 10.1111/j.1471-4159.2005.03123.x

T. Macek, H. Schaffhauser, and P. Conn, Protein kinase C andA3 adenosine receptor activation inhibit presynaptic metabotropic glutamate receptor (mGluR) function and uncouple mGluRs from GTP-binding proteins, J Neurosci, vol.18, pp.6138-6146, 1998.

J. Madrigal, J. Leza, P. Polak, S. Kalinin, and D. Feinstein, Astrocyte-Derived MCP-1 Mediates Neuroprotective Effects of Noradrenaline, Journal of Neuroscience, vol.29, issue.1, pp.263-267, 2009.
DOI : 10.1523/JNEUROSCI.4926-08.2009

M. Matloubian, A. David, S. Engel, J. Ryan, and J. Cyster, A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo, Nature Immunology, vol.1, issue.4, pp.298-304, 2000.
DOI : 10.1038/79738

C. Mckimmie and G. Graham, Astrocytes modulate the chemokine network in a pathogen-specific manner, Biochemical and Biophysical Research Communications, vol.394, issue.4, pp.1006-1011, 2010.
DOI : 10.1016/j.bbrc.2010.03.111

O. Meucci, A. Fatatis, A. Simen, T. Bushell, P. Gray et al., Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity, Proceedings of the National Academy of Sciences, vol.95, issue.24, pp.14500-14555, 1998.
DOI : 10.1073/pnas.95.24.14500
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC24402

S. Moidunny, R. Dias, E. Wesseling, Y. Sekino, H. Boddeke et al., Interleukin-6-type cytokines in neuroprotection and neuromodulation: oncostatin M, but not leukemia inhibitory factor, requires neuronal adenosine A1 receptor function, Journal of Neurochemistry, vol.387, issue.1, pp.1667-1677, 2010.
DOI : 10.1111/j.1471-4159.2010.06881.x

T. Nakayama, K. Hieshima, D. Izawa, Y. Tatsumi, A. Kanamaru et al., Cutting Edge: Profile of Chemokine Receptor Expression on Human Plasma Cells Accounts for Their Efficient Recruitment to Target Tissues, The Journal of Immunology, vol.170, issue.3, pp.1136-1140, 2003.
DOI : 10.4049/jimmunol.170.3.1136

A. Pugliese, E. Coppi, R. Volpini, G. Cristalli, R. Corradetti et al., Role of adenosine A3 receptors on CA1 hippocampal neurotransmission during oxygen???glucose deprivation episodes of different duration, Biochemical Pharmacology, vol.74, issue.5, pp.768-779, 2007.
DOI : 10.1016/j.bcp.2007.06.003

M. Quinones, Y. Kalkonde, C. Estrada, F. Jimenez, R. Ramirez et al., Role of astrocytes and chemokine systems in acute TNF?? induced demyelinating syndrome: CCR2-dependent signals promote astrocyte activation and survival via NF-??B and Akt, Molecular and Cellular Neuroscience, vol.37, issue.1, pp.96-109, 2008.
DOI : 10.1016/j.mcn.2007.08.017

J. Ribeiro and A. Sebastiao, Modulation and metamodulation of synapses by adenosine, Acta Physiologica, vol.276, issue.2, pp.161-169, 2010.
DOI : 10.1111/j.1748-1716.2010.02115.x

J. Ribeiro, A. Sebastiao, and A. De-mendonca, Participation of adenosine receptors in neuroprotection, Drug News & Perspectives, vol.16, issue.2, pp.80-86, 2003.
DOI : 10.1358/dnp.2003.16.2.740246

W. Rostène, P. Kitabgi, and S. Parsadaniantz, Chemokines: a new class of neuromodulator?, Nature Reviews Neuroscience, vol.16, issue.11, pp.895-903, 2007.
DOI : 10.1038/nrn2255

J. Ryu, T. Cho, H. Choi, Y. Wang, and J. Mclarnon, Microglial VEGF Receptor Response Is an Integral Chemotactic Component in Alzheimer's Disease Pathology, Journal of Neuroscience, vol.29, issue.1, pp.3-13, 2009.
DOI : 10.1523/JNEUROSCI.2888-08.2009

S. Saadoun, M. Papadopoulos, H. Watanabe, D. Yan, G. Manley et al., Involvement of aquaporin-4 in astroglial cell migration and glial scar formation, Journal of Cell Science, vol.118, issue.24, pp.5691-5698, 2005.
DOI : 10.1242/jcs.02680

N. Saederup, A. Cardona, K. Croft, M. Mizutani, A. Cotleur et al., Selective Chemokine Receptor Usage by Central Nervous System Myeloid Cells in CCR2-Red Fluorescent Protein Knock-In Mice, PLoS ONE, vol.1, issue.10, pp.13693-13703, 2010.
DOI : 10.1371/journal.pone.0013693.s004

C. Salvatore, S. Tilley, A. Latour, D. Fletcher, B. Koller et al., Disruption of the A3 Adenosine Receptor Gene in Mice and Its Effect on Stimulated Inflammatory Cells, Journal of Biological Chemistry, vol.275, issue.6, pp.4429-4434, 2000.
DOI : 10.1074/jbc.275.6.4429

C. Savarin-vuaillat and R. Ransohoff, Chemokines and chemokine receptors in neurological disease: Raise, retain, or reduce?, Neurotherapeutics, vol.27, issue.4, pp.590-601, 2007.
DOI : 10.1016/j.nurt.2007.07.004

A. Schulte, B. Schulz, M. Andrzejewski, C. Hundhausen, S. Mletzko et al., Sequential processing of the transmembrane chemokines CX3CL1 and CXCL16 by ??- and ??-secretases, Biochemical and Biophysical Research Communications, vol.358, issue.1, pp.233-240, 2007.
DOI : 10.1016/j.bbrc.2007.04.100

M. Schwaninger, M. Neher, E. Viegas, A. Schneider, and M. Spranger, Stimulation of Interleukin-6 Secretion and Gene Transcription in Primary Astrocytes by Adenosine, Journal of Neurochemistry, vol.69, issue.3, pp.1145-1150, 1997.
DOI : 10.1046/j.1471-4159.1997.69031145.x

P. Shaw, V. Forrest, P. Ince, J. Richardson, and H. Wastell, CSF and Plasma Amino Acid Levels in Motor Neuron Disease: Elevation of CSF Glutamate in a Subset of Patients, Neurodegeneration, vol.4, issue.2, pp.209-216, 1995.
DOI : 10.1006/neur.1995.0026

T. Shimaoka, N. Kume, M. Minami, K. Hayashida, H. Kataoka et al., Molecular Cloning of a Novel Scavenger Receptor for Oxidized Low Density Lipoprotein, SR-PSOX, on Macrophages, Journal of Biological Chemistry, vol.275, issue.52, pp.40663-40666, 2000.
DOI : 10.1074/jbc.C000761200

J. Torres-muñoz, C. Van-waveren, M. Keegan, R. Bookman, and C. Petito, Gene expression profiles in microdissected neurons from human hippocampal subregions, Molecular Brain Research, vol.127, issue.1-2, pp.105-114, 2004.
DOI : 10.1016/j.molbrainres.2004.05.017

D. Unutmaz, W. Xiang, M. Sunshine, J. Campbell, E. Butcher et al., The Primate Lentiviral Receptor Bonzo/STRL33 Is Coordinately Regulated with CCR5 and Its Expression Pattern Is Conserved Between Human and Mouse, The Journal of Immunology, vol.165, issue.6, pp.3284-3292, 2000.
DOI : 10.4049/jimmunol.165.6.3284

A. Verkhratsky, O. Krishtal, and G. Burnstock, Purinoceptors on Neuroglia, Molecular Neurobiology, vol.39, issue.3, pp.190-208, 2009.
DOI : 10.1007/s12035-009-8070-3

C. Volonté, M. Ciotti, and L. Battistini, Development of a method for measuring cell number: Application to CNS primary neuronal cultures, Cytometry, vol.11, issue.3, pp.274-276, 1994.
DOI : 10.1002/cyto.990170311

V. Lubitz, D. Carter, M. Deutsch, S. Lin, R. Mastropaolo et al., The effects of adenosine A3 receptor stimulation on seizures in mice, European Journal of Pharmacology, vol.275, issue.1, pp.23-29, 1995.
DOI : 10.1016/0014-2999(94)00734-O

V. Lubitz, D. Simpson, K. Lin, and R. , Right Thing at a Wrong Time?. Adenosine A3 Receptors and Cerebroprotection in Stroke, Annals of the New York Academy of Sciences, vol.232, issue.3-1, pp.85-96, 2001.
DOI : 10.1111/j.1749-6632.2001.tb03615.x

F. White, H. Jung, and R. Miller, Chemokines and the pathophysiology of neuropathic pain, Proceedings of the National Academy of Sciences, vol.104, issue.51, pp.20151-20158, 2007.
DOI : 10.1073/pnas.0709250104

A. Wilbanks, S. Zondlo, K. Murphy, S. Mak, D. Soler et al., Expression Cloning of the STRL33/BONZO/TYMSTR Ligand Reveals Elements of CC, CXC, and CX3C Chemokines, The Journal of Immunology, vol.166, issue.8, pp.5145-5154, 2001.
DOI : 10.4049/jimmunol.166.8.5145

M. Wittendorp, H. Boddeke, and K. Biber, Adenosine A3 receptor-induced CCL2 synthesis in cultured mouse astrocytes, Glia, vol.89, issue.4, pp.410-418, 2004.
DOI : 10.1002/glia.20016

Q. Xu, S. Wang, X. Jiang, Y. Zhao, M. Gao et al., HYPOXIA-INDUCED ASTROCYTES PROMOTE THE MIGRATION OF NEURAL PROGENITOR CELLS VIA VASCULAR ENDOTHELIAL FACTOR, STEM CELL FACTOR, STROMAL-DERIVED FACTOR-1? AND MONOCYTE CHEMOATTRACTANT PROTEIN-1 UPREGULATION IN VITRO, Clinical and Experimental Pharmacology and Physiology, vol.26, issue.7, pp.624-631, 2007.
DOI : 10.1634/stemcells.22-3-415

H. Yao, F. Peng, N. Dhillon, S. Callen, S. Bokhari et al., Involvement of TRPC Channels in CCL2-Mediated Neuroprotection against Tat Toxicity, Journal of Neuroscience, vol.29, issue.6, pp.1657-1669, 2009.
DOI : 10.1523/JNEUROSCI.2781-08.2009

A. Zauner, R. Bullock, A. Kuta, J. Woodward, and H. Young, Glutamate Release and Cerebral Blood Flow After Severe Human Head Injury, Acta Neurochir, vol.67, pp.40-44, 1996.
DOI : 10.1007/978-3-7091-6894-3_9

Y. Zhou, H. Tang, J. Liu, J. Dong, and H. Xiong, Chemokine CCL2 modulation of neuronal excitability and synaptic transmission in rat hippocampal slices, Journal of Neurochemistry, vol.184, issue.3, pp.406-414, 2011.
DOI : 10.1111/j.1471-4159.2010.07121.x

M. Zuurman, J. Heeroma, N. Brouwer, H. Boddeke, and K. Biber, LPS-induced expression of a novel chemokine receptor (L-CCR) in mouse glial cells in vitro and in vivo, Glia, vol.29, issue.4, pp.327-336, 2003.
DOI : 10.1002/glia.10156